| Code | Description | Claims | Beneficiaries | Total Paid |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
14,257 |
11,548 |
$729K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
20,242 |
11,102 |
$688K |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
12,862 |
5,714 |
$586K |
| 99232 |
Subsequent hospital care, per day, moderate complexity |
10,570 |
3,405 |
$306K |
| J9271 |
Injection, pembrolizumab, 1 mg |
35 |
25 |
$249K |
| 99233 |
Prolong inpt eval add15 m |
5,334 |
1,693 |
$237K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
7,339 |
3,897 |
$235K |
| 96367 |
|
10,745 |
4,641 |
$158K |
| J1756 |
Injection, iron sucrose, 1 mg |
4,958 |
2,351 |
$143K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
37,913 |
21,537 |
$136K |
| 99223 |
Prolong inpt eval add15 m |
1,666 |
1,526 |
$130K |
| 99215 |
Prolong outpt/office vis |
1,447 |
1,225 |
$114K |
| J0897 |
Injection, denosumab, 1 mg |
80 |
75 |
$107K |
| 96417 |
|
2,869 |
1,480 |
$81K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
3,881 |
2,701 |
$78K |
| 36415 |
Collection of venous blood by venipuncture |
38,426 |
21,868 |
$62K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
6,385 |
4,510 |
$45K |
| 96368 |
|
5,013 |
2,329 |
$40K |
| 96415 |
|
1,767 |
930 |
$32K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
2,793 |
1,322 |
$20K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
69 |
67 |
$9K |
| J2469 |
Injection, palonosetron hcl, 25 mcg |
1,020 |
493 |
$9K |
| Q5106 |
Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units |
36 |
24 |
$6K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
8,971 |
3,816 |
$4K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
4,403 |
1,865 |
$4K |
| 99205 |
Prolong outpt/office vis |
41 |
38 |
$3K |
| J3420 |
Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg |
2,661 |
2,195 |
$2K |
| 96411 |
|
47 |
25 |
$2K |
| 90756 |
|
117 |
98 |
$2K |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
3,216 |
1,574 |
$1K |
| 99219 |
|
12 |
12 |
$785.26 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
75 |
68 |
$695.85 |
| J9190 |
Injection, fluorouracil, 500 mg |
101 |
50 |
$606.79 |
| J9045 |
Injection, carboplatin, 50 mg |
24 |
12 |
$234.92 |
| J3489 |
Injection, zoledronic acid, 1 mg |
19 |
13 |
$230.44 |
| 96361 |
Intravenous infusion, hydration; each additional hour |
23 |
12 |
$143.42 |
| 90688 |
|
21 |
21 |
$141.93 |
| 36591 |
|
92 |
46 |
$48.06 |
| J0640 |
Injection, leucovorin calcium, per 50 mg |
23 |
13 |
$42.79 |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
17 |
14 |
$25.43 |